Jones Financial Companies
NPCE icon

Jones Financial Companies’s Neuropace NPCE Stock Holding History

Jones Financial Companies’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6K Hold
340
– – ﹤0.01% 4046
2026
Q1 		$4.53K Buy
+340
New +$5.1K ﹤0.01% 3883
2024
Q4 		– Sell
-1,000
Closed -$6.68K – 3475
2024
Q3 		$6.68K Hold
1,000
– – ﹤0.01% 2364
2024
Q2 		$7.56K Buy
+1,000
New +$10.1K ﹤0.01% 1844

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jones Financial Companies's NPCE Position: Q2 2026 in Review

Jones Financial Companies held its Neuropace (NPCE) position steady in Q2 2026 at 340 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4046.

Jones Financial Companies first reported a position in NPCE in Q2 2024 and has held it in 4 quarters since. The position peaked at $7.56K in Q2 2024. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Jones Financial Companies held 340 shares of Neuropace worth $5.6K as of Q2 2026.
  • Jones Financial Companies left its Neuropace share count unchanged in Q2 2026.
  • Neuropace made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4046 holding.
  • Jones Financial Companies first reported a position in Neuropace in Q2 2024 and has held it in 4 quarters since.
  • Jones Financial Companies's Neuropace position peaked at $7.56K in Q2 2024.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.